{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:44:54Z","timestamp":1794638694573,"version":"4.9.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["P01NS097197"],"award-info":[{"award-number":["P01NS097197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","award":["2022-316703"],"award-info":[{"award-number":["2022-316703"]}],"id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-024-00063-9","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T08:02:05Z","timestamp":1712044925000},"page":"1047-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3853-6441","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-6454","authenticated-orcid":false,"given":"Or","family":"Kakhlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5721-653X","authenticated-orcid":false,"given":"Miguel","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9322-0189","authenticated-orcid":false,"given":"Berge A","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"63_CR1","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","volume":"19","author":"C Aguado","year":"2010","unstructured":"Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, Boya P, Sanz P, de Cordoba SR, Knecht E, Rubinsztein DC (2010) Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum Mol Genet 19:2867\u20132876","journal-title":"Hum Mol Genet"},{"key":"63_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00428-019-02633-6","volume":"475","author":"G Cenacchi","year":"2019","unstructured":"Cenacchi G, Papa V, Costa R, Pegoraro V, Marozzo R, Fanin M, Angelini C (2019) Update on polyglucosan storage diseases. Virchows Arch 475:671\u2013686","journal-title":"Virchows Arch"},{"key":"63_CR3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","volume":"21","author":"O Criado","year":"2012","unstructured":"Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millan B, Heredia M, Roma-Mateo C, Mouron S et al (2012) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21:1521\u20131533","journal-title":"Hum Mol Genet"},{"key":"63_CR4","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114554","volume":"13","author":"O Kakhlon","year":"2021","unstructured":"Kakhlon O, Vaknin H, Mishra K, D\u2019Souza J, Marisat M, Sprecher U, Wald-Altman S, Dukhovny A, Raviv Y, Da\u2019adoosh B et al (2021) Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism. EMBO Mol Med 13:e14554","journal-title":"EMBO Mol Med"},{"key":"63_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.15252\/emmm.201707608","volume":"9","author":"F Nitschke","year":"2017","unstructured":"Nitschke F, Sullivan MA, Wang P, Zhao X, Chown EE, Perri AM, Israelian L, Juana-Lopez L, Bovolenta P, Rodriguez de Cordoba S et al (2017) Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. EMBO Mol Med 9:906\u2013917","journal-title":"EMBO Mol Med"},{"key":"63_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/hmg\/ddr452","volume":"21","author":"R Puri","year":"2012","unstructured":"Puri R, Suzuki T, Yamakawa K, Ganesh S (2012) Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Hum Mol Genet 21:175\u2013184","journal-title":"Hum Mol Genet"},{"key":"63_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.celrep.2019.04.017","volume":"27","author":"MA Sullivan","year":"2019","unstructured":"Sullivan MA, Nitschke S, Skwara EP, Wang P, Zhao X, Pan XS, Chown EE, Wang T, Perri AM, Lee JPY et al (2019) Skeletal muscle glycogen chain length correlates with insolubility in mouse models of polyglucosan-associated neurodegenerative diseases. Cell Rep 27:1334\u20131344 e1336","journal-title":"Cell Rep"},{"key":"63_CR8","doi-asserted-by":"publisher","first-page":"19262","DOI":"10.1073\/pnas.0707952104","volume":"104","author":"VS Tagliabracci","year":"2007","unstructured":"Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, Skurat AV, Delgado-Escueta AV, Minassian BA, Depaoli-Roach AA, Roach PJ (2007) Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci USA 104:19262\u201319266","journal-title":"Proc Natl Acad Sci USA"},{"key":"63_CR9","first-page":"28","volume":"7","author":"P Wang","year":"2016","unstructured":"Wang P, Israelian L, Xue Y, Song S, Attisano L, Minassian BA (2016) SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3\/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease. All Results J Biol 7:28\u201333","journal-title":"All Results J Biol"},{"key":"63_CR10","doi-asserted-by":"publisher","first-page":"30412","DOI":"10.1074\/jbc.M606117200","volume":"281","author":"CA Worby","year":"2006","unstructured":"Worby CA, Gentry MS, Dixon JE (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem 281:30412\u201330418","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00063-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:43:27Z","timestamp":1779065007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,16]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00063-9","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patent WO2018154578, awarded to OK and MW, pertains to GHF201 results. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}